Petition: Lobby BC Pharmacare to cover lifesaving SGLT2 inhibitor diabetes treatment

Living With Diabetes | British Columbia, Diabetes Management, Drug Study, Type 2 Diabetes

Author: Dr. Tom Elliott

BCDiabetes Medical Director, Dr. Tom Elliott, has launched a petition to lobby BC Pharmacare to cover SGLT2 inhibitors. As many as 50,000 British Columbians would likely benefit from SGLT2 inhibitors, but many do not have funds or coverage. This class of drug has been shown to reduce mortality for those at high risk of heart attacks and stroke by more than 30 per cent.

https://www.change.org/p/bcpharmacare-lobby-bc-pharmacare-to-cover-lifesaving-sglt2-inhibitor-diabetes-treatment

For more on this drug and BC’s lack of coverage, please see our blog or today’s edition of Metro.